supplementary fig.1

7
Supplementary Fig.1 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 DAOY D 458 M ed M ed8A NCB miR-182 miR-183 Native expression Relative expression ratio vs. HKsRNAs a 0 10 20 30 40 50 60 70 Relative expression ratio vs. pCMX DAOY Med8A Relative expression ratio vs. pCMX Stable overexpression b 0 20 40 60 80 100 120 140 D458 Med Relative expression ratio vs. pCMX 0 1 2 3 4 5 6 7 8 pC M X 182K 1 182K 2 183K 1 183K 2

Upload: halona

Post on 13-Jan-2016

28 views

Category:

Documents


0 download

DESCRIPTION

b. Relative expression ratio vs. pCMX. DAOY. Relative expression ratio vs. pCMX. D458 Med. Relative expression ratio vs. pCMX. Med8A. Stable overexpression. Supplementary Fig.1. a. Relative expression ratio vs. HKsRNAs. Native expression. c. Relative expression ratio vs. siCtrl. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Supplementary Fig.1

Supplementary Fig.1

0.02.04.06.08.0

10.012.014.0

DAOY D458Med

Med8A NCB

miR-182

miR-183

Native expression

Re

lativ

e e

xpre

ssio

nra

tio v

s. H

KsR

NA

sa

0

10

20

30

40

50

60

70

pCMX 182K1 182K2 183K1 183K2

Re

lativ

e e

xpre

ssio

nra

tio v

s. p

CM

X

DA

OY

Med

8AR

ela

tive

exp

ress

ion

ratio

vs.

pC

MX

Stable overexpression

b

0

20

40

60

80

100

120

140

pCMX 182K1 182K2 183K1 183K2

D45

8 M

ed

Re

lativ

e e

xpre

ssio

nra

tio v

s. p

CM

X

012345678

pCMX 182K1 182K2 183K1 183K2

Page 2: Supplementary Fig.1

Supplementary Fig.1

0.0

0.3

0.6

0.9

1.2

1.5

siCtrl si182 siCtrl si183

Re

lativ

e e

xpre

ssio

nra

tio v

s. s

iCtr

lR

ela

tive

exp

ress

ion

ratio

vs.

siC

trl

Transient knockdown

DA

OY

Med

8Ac

0.00.20.40.60.81.01.21.41.6

siCtrl si182 siCtrl si183

Re

lativ

e e

xpre

ssio

nra

tio v

s. s

iCtr

l

D45

8 M

ed

0.0

0.3

0.6

0.9

1.2

1.5

siCtrl si182 siCtrl si183

Page 3: Supplementary Fig.1

Supplementary Fig.2

Page 4: Supplementary Fig.1

Supplementary Fig.3

Page 5: Supplementary Fig.1

Molecular subgroup

miR-182 miR-183 miR-96

Supplementary Fig.4

Page 6: Supplementary Fig.1

Supplementary Fig. 5

Page 7: Supplementary Fig.1

Transient knockdown

0.5

1.0

1.5

2.0

2.5

3.0

3.5

1 2 3 4 5 6 7

DAOY-siCtrlDAOY-si183

DAOY-si182

0.5

1.0

1.5

2.0

2.5

3.0

1 2 3 4 5 6 7

M8A-siCtrl

M8A-si183

M8A-si182

Day

Me

tab

olic

act

ivity

, ra

tio v

s. D

ay1

Me

tab

olic

act

ivity

, ra

tio v

s. D

ay1

0.0

1.0

2.0

3.04.0

5.0

6.0

7.0

8.0

1 2 3 4 5 6 7

DAOY-pCMX

DAOY-183K1

DAOY-183K2

0.0

1.0

2.0

3.04.0

5.0

6.0

7.0

8.0

1 2 3 4 5 6 7

DAOY-pCMX

DAOY-182K1

DAOY-182K2

0.51.01.52.02.53.03.54.04.55.0

1 2 3 4 5 6 7

M8A-pCMXM8A-183K1M8A-183K2

0.51.01.52.02.53.03.54.04.55.0

1 2 3 4 5 6 7

M8A-pCMXM8A-182K1

M8A-182K2

Stable overexpression

Day Day

Me

tab

olic

act

ivity

, ra

tio v

s. D

ay1

Me

tab

olic

act

ivity

, ra

tio v

s. D

ay1

DA

OY

Med

8A

*

*

**

Supplementary Fig. 6